2026 Robert E. Hawkins: Immunology Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Immunology	81	1537	1397	133	126	309	35050
Medicine	81	16406	15431	1497	1431	319	35646

Robert E. Hawkins publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Robert E. Hawkins sits on this spectrum.

62 publications 807+

This scientist: 309 publications — 66th percentile

66% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Robert E. Hawkins D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Robert E. Hawkins sits on this spectrum.

40 D-Index 157+

This scientist: 81 D-Index — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Robert E. Hawkins is affiliated with the University of Manchester in the United Kingdom. Their research spans multiple disciplines within computer science and biology, with significant contributions in artificial intelligence and molecular biology. Hawkins's body of work includes publications in experimental and cognitive psychology, oncology, and pulmonary and respiratory medicine.

The main fields of study for Hawkins include:

Computer Science

The subfields covered by their research are:

Artificial Intelligence
Molecular Biology
Experimental and Cognitive Psychology
Oncology
Pulmonary and Respiratory Medicine

Hawkins's research interests encompass a range of topics, including:

Topic Modeling
Speech and dialogue systems
Language and cultural evolution
Language, Metaphor, and Cognition
Renal cell carcinoma treatment
Natural Language Processing Techniques
CAR-T cell therapy research

Frequently collaborating with various scholars, Hawkins has worked with:

Thomas L. Griffiths
Noah D. Goodman
Theodore R. Sumers
Mark K. Ho
Michael Franke

Their publications have appeared mostly in several venues, with notable repetition in:

arXiv (Cornell University)
Regular and Young Investigator Award Abstracts
Psychological Review
bioRxiv (Cold Spring Harbor Laboratory)
Cognitive Science

Recent papers authored or co-authored by Hawkins include:

"Atezolizumab plus Bevacizumab Versus Sunitinib for Patients with Untreated Metastatic Renal Cell Carcinoma and Sarcomatoid Features: A Prespecified Subgroup Analysis of the IMmotion151 Clinical Trial," 2020, European Urology
"From partners to populations: A hierarchical Bayesian account of coordination and convention," 2022, Psychological Review
"Extracellular vesicles incorporating retrovirus-like capsids for the enhanced packaging and systemic delivery of mRNA into neurons," 2024, Nature Biomedical Engineering
"A Phase I/II Study to Assess the Safety and Efficacy of Pazopanib and Pembrolizumab Combination Therapy in Patients with Advanced Renal Cell Carcinoma," 2021, Clinical Genitourinary Cancer
"Shared functional specialization in transformer-based language models and the human brain," 2024, Nature Communications

Hawkins has also contributed to book publications, including a title published by The MIT Press:

Experimentology, anticipated in 2025

Best Publications

Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma

Robert J Motzer;Nizar M Tannir;David F McDermott;Osvaldo Arén Frontera

4684
Citations
Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma

Brian I. Rini;Elizabeth R. Plimack;Viktor Stus;Rustem Gafanov

3343
Citations
Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial

Cora N. Sternberg;Ian D. Davis;Jozef Mardiak;Cezary Szczylik

3016
Citations
Making Antibodies by Phage Display Technology

Greg Winter;Andrew D. Griffiths;Robert E. Hawkins;Hennie R. Hoogenboom

2491
Citations
Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma

Robert J. Motzer;Thomas E. Hutson;David Cella;James Reeves

2160
Citations
Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial

Brian I Rini;Thomas Powles;Michael B Atkins;Bernard Escudier

1145
Citations
Selection of phage antibodies by binding affinity. Mimicking affinity maturation.

Robert E. Hawkins;Stephen J. Russell;Greg Winter

999
Citations
Cancer classification using the Immunoscore: a worldwide task force

Jérôme Galon;Franck Pagès;Francesco M Marincola;Francesco M Marincola;Helen K Angell;Helen K Angell

961
Citations
A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: Final overall survival results and safety update

Cora N. Sternberg;Robert E. Hawkins;John Wagstaff;Pamela Salman

516
Citations
Randomized, Controlled, Double-Blind, Cross-Over Trial Assessing Treatment Preference for Pazopanib Versus Sunitinib in Patients With Metastatic Renal Cell Carcinoma: PISCES Study

Bernard Escudier;Camillo Porta;Petri Bono;Thomas Powles

475
Citations
Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial

Andrew J Armstrong;Susan Halabi;Tim Eisen;Samuel Broderick

458
Citations
The clinical efficacy of first-generation carcinoembryonic antigen (CEACAM5)-specific CAR T cells is limited by poor persistence and transient pre-conditioning-dependent respiratory toxicity.

Fiona C. Thistlethwaite;Fiona C. Thistlethwaite;David E. Gilham;Ryan D. Guest;Dominic G. Rothwell

454
Citations
The role of extracellular spacer regions in the optimal design of chimeric immune receptors: evaluation of four different scFvs and antigens.

Ryan D Guest;Robert E Hawkins;Natalia Kirillova;Eleanor J Cheadle

404
Citations
Marimastat as maintenance therapy for patients with advanced gastric cancer: a randomised trial

S R Bramhall;M T Hallissey;J Whiting;J Scholefield

372
Citations
Clinical evidence of efficient tumor targeting based on single-chain Fv antibody selected from a combinatorial library.

R.H.J. Begent;M.J. Verhaar;K.A. Chester;J.L. Casey

356
Citations
The optimal antigen response of chimeric antigen receptors harboring the CD3zeta transmembrane domain is dependent upon incorporation of the receptor into the endogenous TCR/CD3 complex.

John S Bridgeman;Robert E Hawkins;Steven Bagley;Morgan Blaylock

341
Citations
Retroviral vectors displaying functional antibody fragments

Stephen J. Russell;Robert E. Hawkins;Greg Winter

299
Citations
Modulation of Lymphocyte Regulation for Cancer Therapy: A Phase II Trial of Tremelimumab in Advanced Gastric and Esophageal Adenocarcinoma

Christy Ralph;Eyad Elkord;Deborah J. Burt;Jackie F. O'Dwyer

292
Citations
The clinical and histologic criteria that predict metastases from cystosarcoma phyllodes.

Robert E. Hawkins;John B. Schofield;Cyril Fisher;Eve Wiltshaw

280
Citations
CAR-T cells and solid tumors: tuning T cells to challenge an inveterate foe.

David E. Gilham;Reno Debets;Martin Pule;Robert E. Hawkins

248
Citations

Frequent Co-Authors

Peter L. Stern University of Manchester

Camillo Porta University of Bari Aldo Moro

Eyad Elkord Xi’an Jiaotong-Liverpool University

Thomas Powles Queen Mary University of London

Cora N. Sternberg Cornell University

Stéphane Oudard Hôpital Européen Georges-Pompidou

Brian I. Rini Vanderbilt University Medical Center

Alain Ravaud University of Bordeaux

Robert J. Motzer Memorial Sloan Kettering Cancer Center

Stephen J. Russell Mayo Clinic

External Links

Personal website of Robert E. Hawkins

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

For those interested in immunology, pursuing related healthcare degrees online can open diverse career pathways. Many students start with foundational programs like online adn programs for non nurses, designed for individuals transitioning into nursing without prior experience. These programs provide essential clinical skills while accommodating working professionals.

If you’re aiming for a quicker route to become a registered nurse, easiest accelerated nursing programs to get into offer streamlined curricula that prepare students for licensure in less time. Such degrees can be an ideal stepping stone toward advanced immunology-related roles.

For those seeking entry-level opportunities, lpn programs easy to get into provide foundational training with flexible admission standards. Licensed Practical Nurses often work closely with immunologists and healthcare teams, gaining valuable experience in patient care.

Advancing further, many explore what is the easiest np program to find nurse practitioner degrees with manageable prerequisites. Becoming a Nurse Practitioner expands clinical responsibilities and opportunities to specialize in immunology-focused healthcare settings.